Paul Talmo - Feb 23, 2024 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Technology Officer
Signature
/s/ Megan Smeykal, Attorney-in-fact
Stock symbol
TELA
Transactions as of
Feb 23, 2024
Transactions value $
-$25,636
Form type
4
Date filed
2/27/2024, 04:35 PM
Previous filing
Apr 4, 2023
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +16.7K +29.83% $0.00 72.7K Feb 23, 2024 Direct F1
transaction TELA Common Stock Tax liability -$18.2K -2.58K -3.55% $7.07 70.1K Feb 23, 2024 Direct F2
transaction TELA Common Stock Tax liability -$7.42K -1.05K -1.5% $7.07 69.1K Feb 24, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +24.4K $0.00 24.4K Feb 23, 2024 Common Stock 24.4K $7.07 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
F3 The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.